cytarabine and B-Cell Lymphoma

cytarabine has been researched along with B-Cell Lymphoma in 149 studies

Research

Studies (149)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	23 (15.44)	18.2507
2000's	69 (46.31)	29.6817
2010's	52 (34.90)	24.3611
2020's	5 (3.36)	2.80

Authors

Authors	Studies
Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L	1
Biffi, A; Buffardi, S; Buldini, B; Carraro, E; Cavallaro, E; Cellini, M; D'Amore, ESG; Damanti, CC; Gallingani, I; Lovisa, F; Micalizzi, C; Mussolin, L; Piglione, M; Pillon, M; Sala, A; Santoro, N; Vinti, L	1
de Castro, DG; Dietrich, S; Dreger, P; Dreyling, M; Grabe, N; Hermine, O; Hoster, E; Hüttl, K; Klapper, W; Kluin-Nelemans, HC; Müller-Tidow, C; Ott, G; Pott, C; Roider, T; Rosenwald, A; Stewart, JP; Wang, X	1
Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L	1
A Rouche, J; Abdayem, P; Danu, A; Dartigues, P; Desmaris, R; El Dakdouki, Y; Fermé, C; Ghez, D; Ibrahim, N; Lazarovici, J; Michot, JM; Ribrag, V; Rossignol, J; Willekens, C	1
Amengual, JE; Barta, SK; Bast, MA; Behdad, A; Blum, KA; Calzada, O; Cassaday, RD; Chavez, JC; Cohen, JB; Costa, C; Falkiewicz, MK; Feldman, T; Fenske, TS; Gerson, JN; Hernandez-Ilizaliturri, F; Hill, BT; Howlett, C; Kaplan, JB; Landsburg, DJ; Lansigan, F; Li, S; Lue, JK; Maly, J; Mato, AR; Medeiros, LJ; Nathan, S; Olszewski, AJ; Peace, DJ; Persky, DO; Petrich, AM; Reddy, NM; Rivera, X; Singavi, A; Torka, P; Vose, JM	1
Hou, AJ; Jia, RF; Jiang, L; Yang, XY	1
Aricò, M; Basso, G; Buffardi, S; Carraro, E; Conter, V; d'Amore, ESG; Mura, R; Mussolin, L; Pierani, P; Pillon, M; Sala, A; Tondo, A; Vinti, L	1
Chen, Z; Mishra, AK; Pan, Z; Ren, W; Silva, A; Wang, JH; Wang, X	1
Diepstra, A; Huls, G; Kibbelaar, R; Nijland, M; Seitz, A; van den Berg, A; van Meerten, T; Visser, L	1
Bellò, M; Benevolo, G; Bisi, G; Boccomini, C; Botto, B; Castellino, A; Chiappella, A; Ciochetto, C; Freilone, R; Nicolosi, M; Orsucci, L; Passera, R; Pecoraro, C; Pregno, P; Vitolo, U	1
Chen, CD; Jiang, H; Li, X; Liu, M; Zhang, Y; Zheng, L	1
Carli, G; D'Amore, ESG; Di Bona, E; Famengo, B; Paolini, R; Perbellini, O; Piazza, F; Ravelli, E; Ruggeri, M; Sartori, R; Tecchio, C; Tisi, MC; Visco, C	1
Kállay, K; Kassa, C; Kertész, G; Kriván, G; Reményi, P; Sinkó, J	1
Arcani, R; Colle, J; Costello, RT; Fanciullino, R; Farnault, L; Ivanov, V; Jourde-Chiche, N; Mercier, C; Pourroy, B; Roche, P; Venton, G	1
Sun, B; Wang, Y; Xu, X; Zhang, L; Zhang, Q; Zhang, Y	1
Czuczman, MS; Edvardsen, K; Fayad, L; Fecteau, D; Fennessy, M; Henkel, K; Jewell, RC; Joyce, R; Kharfan-Dabaja, MA; Liao, Q; Lisby, S; Lossos, IS; Matasar, MJ; Moskowitz, CH; Rodriguez, MA; Shea, TC; Singh, RP; Spitzer, G	1
Gisselbrecht, C	1
Hudson, MM; Kastan, MB; Kennedy, W; Onciu, M; Sandlund, JT	1
Auperin, A; Baruchel, A; Bergeron, C; Bertrand, Y; Coze, C; Lacombe, MJ; Lervat, C; Leverger, G; Méchinaud, F; Munzer, M; Nelken, B; Patte, C	1
Cairo, MS; Galardy, PJ; Goldman, S; Harrison, L; Hochberg, J; Perkins, SL	1
Aoki, H; Fujii, Y; Isogawa, M; Natsumeda, M; Ogura, R; Okada, M; Tsukamoto, Y; Yoshida, S	1
Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I	1
Chwee, JY; Gasser, S; Huang, CW; Le Bert, N; Lee, SK; Ma, CA	1
Imai, H; Komatsu, N; Nakamura, N; Noguchi, M; Sawada, T; Sekiguchi, Y; Shimada, A; Sugimoto, K; Wakabayashi, M	1
Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H	1
Ando, K; Kawada, H; Kobayashi, H; Miyamoto, M; Murayama, H; Ogawa, Y; Ohmachi, K; Onizuka, M; Sawanobori, M; Shirasugi, Y; Tazume, K; Toyosaki, M; Tsuboi, K; Tsuma-Kaneko, M; Wasada, I	1
Hasegawa, K; Hirayama, Y; Ishihara, T; Kanagawa, M; Koyama, J; Suzuki, T; Terui, T	1
Banat, A; Basara, N; Derigs, G; Flohr, T; Frickhofen, N; Gramatzki, M; Hess, G; Kirschey, S; Kolbe, K; Link, H; Meyer, RG; Peter, N; Schmitz, N; Schulz, A; Theobald, M; Weidmann, E; Wolf, HH	1
Barth, MJ; Czuczman, MS; Frys, S; Gu, JJ; Hernandez-Ilizaliturri, FJ; Hu, Q; Mavis, C; Simons, Z; Skitzki, J; Song, L	1
Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD	1
Croxson, G; Halmagyi, GM; McCluskey, P; O'Connor, L	1
Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP	1
Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E	1
Amin, K; Barbarotta, L; Gore, SD; Kasberg, S; Kim, TK; Podoltsev, NA; Prebet, T; Roche, K; Stahl, M; Xu, ML; Zeidan, AM	1
DU, CY; Duan, LJ; Li, C; Yang, RY	1
Alptekin, M; Erkutlu, I; Kilciksiz, S; Okan, V; Pehlivan, M; Sari, I; Yilmaz, M	1
Kravchenko, SK; Kremenetskaia, AM; Lorie, IuIu; Obukhova, TN; Vorob'ev, IA; Vorob'ev, VI; Zvonkov, EE	1
Erwin, W; Evens, AM; Gordon, LI; Inwards, DJ; Mehta, J; Micallef, I; Molina, A; Patton, D; Rademaker, AW; Singhal, S; Spies, S; Tallman, MS; Weitner, BB; White, CA; Williams, SF; Winter, JN; Wiseman, G; Zimmer, M	1
Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S	1
Asai, T; Hangaishi, A; Imai, T; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K; Yamamoto, G	1
Iwasaki, M; Oshima, K; Sakaura, H; Yamashita, T; Yoshikawa, H	1
Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N	1
Bosi, A; Chiappella, A; Chitarrelli, I; Fabbri, A; Lauria, F; Levis, A; Puccini, B; Rigacci, L; Vitolo, U	1
Brice, P; Briere, J; Faure, P; Franchi, P; Gisselbrecht, C; Lignon, J; Madelaine, I; Mounier, N; Sibon, D; Thieblemont, C	1
Kato, J; Mori, T; Okamoto, S; Shimizu, T; Tsukada, Y; Ueda, T; Yokoyama, K	1
Ardeshna, KM; Goldstone, AH; Kayani, I; Linch, DC; Lowry, L; Marafioti, T; Mohamedbhai, SG; Sibson, K	1
Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T	1
Al-Darraji, AF; Al-Hadad, SA; Al-Jadiry, MF; Al-Saeed, RM; De Vellis, A; Foà, R; Moleti, ML; Piciocchi, A; Testi, AM; Uccini, S	1
Glass, B; Griesinger, F; Hasenkamp, J; Hohloch, K; Lakhani, VJ; Meller, J; Riggert, J; Sahlmann, CO; Trümper, L; Wulf, G	1
Csomor, J; Deák, B; Gaudi, I; Lengyel, Z; Lovey, J; Matolcsy, A; Molnár, Z; Petri, K; Rosta, A; Schneider, T; Tóth, E; Várady, E	1
Bologna, S; Bosly, A; Bouabdallah, K; Brière, J; Coiffier, B; Decaudin, D; Delarue, R; Ghesquières, H; Gisselbrecht, C; Huynh, A; Le Gouill, S; Morschhauser, F; Mounier, N; Ribrag, V; Tilly, H	1
Chiba, S; Hasegawa, Y; Kondo, Y; Kurita, N; Nakamoto, R; Nakamura, N; Nishikii, H; Noguchi, M; Okoshi, Y; Suzukawa, K; Yokoyama, Y	1
Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Miura, K; Sawada, U; Takei, K; Takeuchi, J; Tanaka, T; Yagi, M; Yamazaki, T	1
Hori, M; Nishida, H; Obara, K	1
Adrada, BE; Carkaci, S; Whitman, GJ	1
Arcamone, M; Becchimanzi, C; Capobianco, G; Corazzelli, G; De Chiara, A; De Filippi, R; Esposito, G; Frairia, C; Frigeri, F; Marcacci, G; Morelli, E; Pinto, A; Russo, F; Saggese, M; Vitolo, U; Volzone, F	1
de Rooij, M; Huijgens, PC; Visser, OJ; Wondergem, MJ; Zijlstra, JM; Zweegman, S	1
Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C	1
Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R	1
Buerger, T; Gebauer, T; Halloul, Z; Meyer, F	1
Chen, H; Chen, J; Fu, RY; Gu, LJ; Pan, C; Tang, JY; Wang, YP; Wu, Y; Xue, H; Zhao, H	1
Berkow, RL; Hilliard, LM; Watts, RG	1
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J	1
Lauterbach, I; Mann, G; Niemeyer, C; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Seidemann, K; Simonitsch, I; Stankewitz, K; Tiemann, M; Zimmermann, M	1
Boccadoro, M; Caracciolo, D; Cuttica, A; Dell'Aquila, M; Di Nicola, M; Gianni, AM; Ladetto, M; Magni, M; Marinone, C; Pileri, A; Rosace, M; Tarella, C; Zallio, F	1
Fehlings, T; Grehl, S; Kleuker, S; Pöttgen, C; Rauhut, F; Schmitz, A; Schwechheimer, K; Stüben, G; Stuschke, M; Wacker, HH; Wilhelm, H	1
Hoang-Xuan, K; Levy, V; Soussain, C	1
Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L	1
Blystad, AK; Delabie, J; Holte, H; Ikonomou, I; Kvalheim, G; Kvaløy, S; Vålerhaugen, H	1
Chajek-Shaul, T; Cukierman, T; Ilsar, M; Liebster, D; Planer, D	1
Ghesani, M; Harandi, A; Polosajian, L; Sara, G; Tupper, T	1
Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S	1
Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E	1
Boruczkowski, D; Choma, M; Chybicka, A; Drabko, K; Gorczyńska, E; Kałwak, K; Kowalczyk, JR; Pieczonka, A; Toporski, J; Turkiewicz, D; Wachowiak, J; Wójcik, B; Zaucha-Prazmo, A	1
Ikeda, K; Matsumoto, K; Matsuoka, S; Ohta, M; Takeshita, I	1
Acholonu, S; Anderlini, P; Champlin, RE; Couriel, D; De Lima, M; Donato, ML; Fayad, L; Giralt, S; Hosing, C; Jones, R; Khouri, IF; Korbling, M; Maadani, F; Manning, JT; McLaughlin, P; Okoroji, GJ; Pro, B; Saliba, RM; Shpall, E; Younes, A	1
Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J	1
Benedetti, F; Cantini, M; Crippa, C; Draisci, M; Pasini, F; Pizzolo, G; Tecchio, C; Todeschini, G	1
Crump, M; Lin, B; Shepherd, L	1
Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T	1
Beitler, B; Bellesso, M; Chamone, D; de Almeida Macedo, MC; Dias, LC; Dorlhiac-Llacer, PE; Dulley, FL; Neto, AE; Pereira, J; Pracchia, LF	1
Antonenas, V; Bradstock, K; Collins, D; Crowther, H; Gottlieb, D; Kerridge, I; McGurgan, M	1
Aoyama, Y; Hagihara, K; Hino, M; Hirai, M; Hirose, A; Kanashima, H; Koh, KR; Kosaka, S; Kumura, T; Manabe, M; Mugitani, A; Nakajima, Y; Nakamae, M; Nakao, Y; Ohta, K; Sakamoto, C; Sakamoto, E; Terada, Y; Teshima, H; Yamane, T	1
Drach, J; Hejna, M; Jaeger, U; Raderer, M; Skrabs, C; Woehrer, S; Zielinski, CC	1
Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F	1
Hino, M; Hirose, A; Koh, H; Mugitani, A; Nakajima, Y; Nakamae, H; Nakamae, M; Nakane, T; Nakao, Y; Takeoka, Y; Teshima, H; Yagi, T; Yamamura, R; Yamane, T	1
Gisselbrecht, C; Hagberg, H	1
Adde, M; Enblad, G; Hagberg, H; Laurell, A; Sundström, C	1
Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M	1
Beitler, B; Chamone, DA; Chaoubah, A; Dulley, FL; Hallack Neto, AE; Llacer, PD; Macedo, MC; Pereira, J	1
Birkmann, J; Bopp, C; Flieger, D; Florschütz, A; Glasmacher, AG; Gorschlüter, M; Hahn, C; Hensel, M; Ho, AD; Kaiser, U; Mey, UJ; Neubauer, A; Orlopp, KS; Rabe, C; Schmidt-Wolf, IG; Strehl, JW; Wilhelm, M	1
Agarwal, R; Arkenau, HT; Chong, G; Cunningham, D; Horwich, A; Norman, A; Sirohi, B; Trumper, M; Watkins, D; Wotherspoon, A	1
Crump, M	1
Flieger, D; Glasmacher, AG; Gorschlueter, M; Hensel, M; Mey, UJ; Olivieri, A; Orlopp, KS; Rabe, C; Schmidt-Wolf, IG; Strehl, JW	1
Allievi, C; Bernareggi, A; Cabanillas, F; Fayad, L; Laffranchi, B; Levine, AM; Lim, ST; Modiano, M; Tulpule, A	1
Huijgens, PC; Keijzer, A; van de Loosdrecht, AA	1
Ishizawa, K	1
Estella, J; Fernández-Delgado, R; Forns, M; Gallego, S; García-Miguel, P; Indiano, JM; Javier, G; Navajas, A; Pardo, N	1
Boccadoro, M; Bregni, M; Cabras, A; Calvi, R; Caracciolo, D; Comino, A; Corradini, P; Devizzi, L; Di Nicola, M; Fornari, A; Gallamini, A; Gianni, AM; Ladetto, M; Magni, M; Majolino, I; Mirto, S; Novero, D; Patti, C; Pescarollo, A; Ponzoni, M; Remotti, D; Rosato, R; Stella, M; Tarella, C; Zanni, M; Zoli, V	1
Ahn, HS; Chang, HM; Huh, J; Kang, HJ; Kang, YK; Kim, MJ; Kim, TW; Lee, H; Lee, JL; Lee, Y; Park, JH; Ryu, MH; Yoo, C	1
Kiratli, PO	1
Ansell, SM; Colgan, JP; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, KM; Simpson, L; Witzig, TE	1
Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P	1
Saitou, K; Saitou, Y; Suzuki, S; Uzuka, Y; Yamaguchi, M	1
Chi, HS; Huh, J; Jang, S; Kim, MK; Kim, S; Kim, SW; Lee, DH; Lee, SS; Park, CJ; Suh, C; Sym, SJ	1
Fibbe, WE; Huijgens, PC; Lugtenburg, PJ; van 't Veer, MB; van Imhoff, GW; van Oers, MH; van Putten, WL; Vellenga, E; Verdonck, LF; Wijermans, PW; Zijlstra, JM	1
Kagami, Y; Kato, H; Kikuchi, A; Morishima, Y; Ogura, M; Oki, Y; Oshiro, A; Taji, H; Tsujimura, A; Yamamoto, K	1
Barsaoui, S; Benchekroun, S; Bouhas, R; Doumbé, P; Harif, M; Khattab, M; Ladjaj, Y; Lemerle, J; Moreira, C; Msefer-Alaoui, F; Patte, C; Rakotonirina, G; Raphael, M; Raquin, MA	1
Auperin, A; Cairo, MS; Gerrard, M; Lacombe, MJ; Lambilliote, A; McCarthy, K; Patte, C; Perkins, SL; Pinkerton, R; Sposto, R; Weston, C	1
Fujimoto, J; Kikuchi, A; Kumagai, M; Mori, T; Okimoto, Y; Sunami, S; Tsuchida, M	1
Falini, B; Giovannini, M; Martélli, M; Martelli, MF; Mazza, P; Pasqualucci, L; Pescarmona, E; Pileri, S; Santucci, A; Venturi, S	1
Crowther, D; Ghielmini, M; Morgenstern, GR; Pettengell, R; Radford, JA; Scheid, C; Stern, PL	1
Khan, A; Moorthy, RS; Rao, NA; Valluri, S	1
Frappaz, D; Leverger, G; Michon, J; Patte, C; Pico, JL; Rubie, H; Soussain, C	1
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW	1
Agur, Z; Schechter, B; Tagliabue, G; Ubezio, P	1
Carr, TF; DaCosta, PE; Kelsey, AM; Lewis, I; Lockwood, L; Morris-Jones, PH; Stevens, RF	1
Babini, L; Bendandi, M; Frezza, G; Gherlinzoni, F; Magagnoli, M; Merla, E; Salvucci, M; Tura, S; Zinzani, PL	1
Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K	1
Amin, K; Anderlini, P; Andersson, B; Cabanillas, F; Champlin, R; Claxton, D; de Lima, M; Donato, M; Gajewski, J; Giralt, S; Khouri, I; Mehra, R; Popat, U; Preti, A; Przepiork, D; Pugh, W; Rodriguez, A; Rodriguez, J; Romaguera, J; van Besien, K	1
Azaceta, G; Palomera, L; Soria, J; Varo, MJ	1
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Magrath, I; Neely, J; Nieder, M; Owen, W; Seibel, N; Shad, A; Venzon, D; Wilson, W	1
Ashley, S; Atra, A; Gerrard, M; Hobson, R; Imeson, JD; Pinkerton, CR	1
Cunningham, D; Popescu, RA; Wotherspoon, AC	1
den Boer, ML; Durian, M; Janka, G; Kaspers, GJ; Pieters, R; Schmiegelow, K; van Wering, ER; Veerman, AJ	1
Amigo, ML; del Cañizo, MC; Gonzalez, MB; Gutiérrez, N; Hernández, JM; Mateos, MV; San Miguel, JF	1
Brouwers, P; deSmet, M; Heiss, J; Jaffe, E; Kohler, D; Nussenblat, R; Patronas, N; Pearson, D; Sandor, V; Simon, R; Stark-Vancs, V; Whitcup, SM; Wittes, R	1
De Sanctis, V; Donato, V; Mandelli, F; Martelli, M; Martelli, MP; Palombi, F; Pau, FM; Pescarmona, E; Rendina, EA; Todisco, E	1
Ohno, R; Takeshita, A	1
Buthmann, U; Freund, M; Kleine, HD; Volk, J	1
Nath, N; Neild, GH; Plowman, PN	1
Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Mateo-Navarro, A; Rodilla Sala, E; Ruíz-Hernández, G; Solano-Vercet, C; Terol-Castera, MJ	1
Chizzali-Bonfadin, C; Filipits, M; Heinzl, H; Jaeger, U; Pirker, R; Simonitsch, I	1
Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F	1
Beham-Schmid, C; Hoefler, G; Linkesch, W; Neumeister, P; Sill, H	1
Douglas, R; Michael, B; Nabil, S; Thomas, F	1
Atra, A; Gerrard, M; Hann, IM; Hobson, R; Imeson, JD; Pinkerton, CR	1
Auperin, A; Behrendt, H; Coze, C; Frappaz, D; Leverger, G; Lutz, P; Michon, J; Patte, C; Perel, Y; Raphaël, M; Terrier-Lacombe, MJ	1
Marsot Dupuch, K; Yeshurun, M	1
Akdeniz, S; Devecioglu, C; Haspolat, K; Soker, M	1
Ekman, T; Goldkuhl, C; Telhaug, R; Wiklund, T	1
Armata, J; Balcerska, A; Bogusławska-Jaworska, J; Bubala, H; Dluzniewska, A; Gacka, M; Jaworski, W; Jeleń, M; Kazanowska, B; Kowalczyk, J; Kołecki, P; Kurylak, A; Matysiak, M; Ploszyńska, A; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopylo, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G; Wysocki, M	1
Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C	1
Bargou, R; Dörken, B; Fiehn, C; Heilig, B; Mapara, M	1
Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S	1
Fujita, T; Ito, M; Matsui, T; Nakao, Y; Natazuka, T; Sugimoto, T	1
Behrendt, H; Dufillot, D; Gentet, JC; Lamagnère, JP; Otten, J; Patte, C; Pein, F; Philip, T; Rodary, C; Zucker, JM	1
Barnes, J; Eden, OB; Hann, IM; Pinkerton, CR	1

Reviews

4 review(s) available for cytarabine and B-Cell Lymphoma

Article	Year
Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:4 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Prednisone; Proto-Oncogene Proteins c-myc; Radiotherapy; Rituximab; Translocation, Genetic; Treatment Outcome; Vincristine; Whole-Body Irradiation	2013
Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-CHOP therapy and intrathecal administration: a case report and review of literature. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:6 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Injections, Spinal; Lung Neoplasms; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Pons; Prednisolone; Prednisone; Remission Induction; Rituximab; Vascular Neoplasms; Vincristine	2014
Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Bailliere's clinical haematology, 1994, Volume: 7, Issue:2 Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Male; Methotrexate; Multicenter Studies as Topic; Nasopharyngeal Neoplasms; Neoplasm Staging; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine	1994
[New combination therapies in hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporins; Cytarabine; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Myelodysplastic Syndromes; Prednisone; Quinolines; Rituximab; Tretinoin; Vidarabine; Vincristine	2000

Trials

43 trial(s) available for cytarabine and B-Cell Lymphoma

Article	Year
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial. International journal of cancer, 2021, 01-01, Volume: 148, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Mutation; Oxaliplatin; Prednisone; Primary Cell Culture; Rituximab; SAM Domain and HD Domain-Containing Protein 1; Tissue Array Analysis; Vidarabine; Vincristine	2021
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial. British journal of haematology, 2021, Volume: 192, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous	2021
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience. Annals of hematology, 2018, Volume: 97, Issue:9 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Invasiveness; Podophyllotoxin; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult; Yttrium Radioisotopes	2018
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma. American journal of hematology, 2018, Volume: 93, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Female; Humans; Italy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pilot Projects; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult	2018
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma. Blood, 2013, Jul-25, Volume: 122, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Recurrence; Survival Analysis; Treatment Failure; Young Adult	2013
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report. British journal of haematology, 2013, Volume: 163, Issue:3 Topics: Acute Kidney Injury; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Hyperuricemia; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Proteins; Pilot Projects; Prednisone; Prospective Studies; Rituximab; Tumor Lysis Syndrome; Urate Oxidase; Vincristine; Young Adult	2013
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. British journal of haematology, 2014, Volume: 167, Issue:3 Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine	2014
Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma. The Tokai journal of experimental and clinical medicine, 2014, Sep-20, Volume: 39, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Rituximab; Salvage Therapy; Treatment Outcome	2014
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study. British journal of haematology, 2015, Volume: 168, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Patient Selection; Prospective Studies; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Young Adult	2015
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. The Lancet. Haematology, 2016, Volume: 3, Issue:5 Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom	2016
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Apr-01, Volume: 27, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Female; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Radioimmunotherapy; Radiotherapy Dosage; Salvage Therapy; Transplantation, Autologous	2009
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols. American journal of hematology, 2010, Volume: 85, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult	2010
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue. Annals of hematology, 2011, Volume: 90, Issue:11 Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Myeloablative Agonists; Prospective Studies; Radioimmunotherapy; Recurrence; Rituximab; Salvage Therapy; Stem Cell Transplantation	2011
(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study. Clinical lymphoma, myeloma & leukemia, 2011, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Melphalan; Middle Aged; Neoplasm Staging; Podophyllotoxin; Rituximab; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult	2011
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma. British journal of haematology, 2012, Volume: 156, Issue:2 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Spinal; Liposomes; Lymphoma, B-Cell; Male; Middle Aged; Rituximab	2012
Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group. Medical and pediatric oncology, 2002, Volume: 39, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Male; Mesna; Methotrexate; Prednisone; Treatment Outcome; Vincristine	2002
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatric blood & cancer, 2004, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine	2004
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome	2005
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine	2005
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive Clinical lymphoma, 2005, Volume: 6, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cytarabine; Deoxycytidine; Dexamethasone; Gemcitabine; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Rituximab	2005
Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. Leukemia research, 2006, Volume: 30, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cytarabine; Developing Countries; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Transplantation, Autologous	2006
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL). Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine	2006
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome	2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer investigation, 2006, Volume: 24, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome	2006
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis. Leukemia & lymphoma, 2006, Volume: 47, Issue:12 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prospective Studies; Recurrence; Rituximab; Salvage Therapy	2006
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Isoquinolines; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Salvage Therapy; Treatment Outcome	2007
[Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma]. Medicina clinica, 2007, May-05, Volume: 128, Issue:17 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Prospective Studies; Vincristine	2007
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome	2007
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood, 2008, Jan-15, Volume: 111, Issue:2 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous	2008
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer science, 2008, Volume: 99, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Immunotherapy; Lymphoma, B-Cell; Middle Aged; Rituximab; Salvage Therapy; Stem Cell Transplantation	2008
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. British journal of haematology, 2008, Volume: 141, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine	2008
Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol. Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Lymphoma, B-Cell; Methotrexate; Neoplasms, Second Primary; Recurrence; Survival Analysis; Treatment Outcome	2008
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. British journal of haematology, 1995, Volume: 89, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Immunohistochemistry; Lymphoma, B-Cell; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisolone; Survival Analysis; Treatment Outcome; Vincristine	1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors	1995
Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leukemia & lymphoma, 1996, Volume: 21, Issue:3-4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Evaluation Studies as Topic; Female; Fluorouracil; Gallium Radioisotopes; Humans; Leucovorin; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Sclerosis; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vincristine	1996
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Seminars in oncology, 1998, Volume: 25, Issue:2 Suppl 4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Vincristine	1998
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. British journal of cancer, 1998, Volume: 77, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Lymphoma, B-Cell; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine	1998
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Drug Administration Schedule; Eye Neoplasms; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Pilot Projects; Thiotepa; Vincristine	1998
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Sclerosis; Survival Rate; Treatment Outcome; Vincristine	1998
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa	2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 2001, Jun-01, Volume: 97, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Rate; Vincristine	2001
Age-adjusted chemotherapy for primary central-nervous system lymphoma--a pilot study. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:1 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Injections, Spinal; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Pilot Projects; Radiotherapy, Adjuvant; Vincristine	2002
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Infant; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Survival Rate; Vincristine	1991

Other Studies

102 other study(ies) available for cytarabine and B-Cell Lymphoma

Article	Year
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood advances, 2022, 11-22, Volume: 6, Issue:22 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine	2022
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration. British journal of haematology, 2020, Volume: 189, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Lymphoma, B-Cell; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Prednisone; Retrospective Studies; Vincristine	2020
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy. European journal of haematology, 2021, Volume: 106, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Rituximab; Treatment Outcome	2021
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jul-10, Volume: 35, Issue:20 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine	2017
Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports. Medicine, 2017, Volume: 96, Issue:39 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Vincristine	2017
Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20. Pediatric blood & cancer, 2018, Volume: 65, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Retrospective Studies; Rituximab; Survival Rate	2018
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition. Haematologica, 2018, Volume: 103, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cells, Cultured; Cytarabine; DNA Damage; Doxorubicin; Drug Synergism; Humans; Lymphoma, B-Cell; Mice; Nuclear Proteins; Protein-Tyrosine Kinases	2018
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma. Annals of hematology, 2018, Volume: 97, Issue:5 Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Janus Kinase 1; Janus Kinase 2; Lymphoma, B-Cell; Mediastinal Neoplasms; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Prednisone; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Vincristine	2018
UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma. Nature communications, 2018, 07-13, Volume: 9, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; B-Lymphocytes; Brain Neoplasms; Carcinogenesis; Cytarabine; Drug Resistance, Neoplasm; Ephrin-B1; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Histone Demethylases; Humans; Lymphoma, B-Cell; Male; Mice; Mice, Knockout; Neoplasms, Experimental; Sex Factors; Signal Transduction; Survival Analysis; X Chromosome Inactivation	2018
Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder. Pediatric transplantation, 2018, Volume: 22, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Child; Cytarabine; Epstein-Barr Virus Infections; Female; Fusion Proteins, bcr-abl; Humans; Immunosuppression Therapy; Injections, Spinal; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, B-Cell; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Nivolumab; Positron Emission Tomography Computed Tomography; Postoperative Period; Remission Induction; Rituximab; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome	2018
Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen. Bone marrow transplantation, 2019, Volume: 54, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Humans; Lymphoma, B-Cell; Male; Melphalan; Podophyllotoxin; Renal Insufficiency; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning	2019
Ofatumumab in diffuse large B cell lymphoma? Blood, 2013, Jul-25, Volume: 122, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male	2013
Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies. Pediatric blood & cancer, 2014, Volume: 61, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Vincristine; Young Adult	2014
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study. Pediatric blood & cancer, 2014, Volume: 61, Issue:3 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; L-Lactate Dehydrogenase; Leucovorin; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine	2014
Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution. Neurologia medico-chirurgica, 2013, Volume: 53, Issue:11 Topics: Academies and Institutes; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Female; Hematologic Diseases; Hospitals, University; Humans; Kaplan-Meier Estimate; Kidney Diseases; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Procarbazine; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult	2013
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. Leukemia & lymphoma, 2015, Volume: 56, Issue:1 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult	2015
Synergistic anticancer effects of Pam3CSK4 and Ara-C on B-cell lymphoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-01, Volume: 20, Issue:13 Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Line, Tumor; Cell Transformation, Neoplastic; Cluster Analysis; Cytarabine; Disease Models, Animal; Drug Synergism; Enzyme Activation; Gene Expression Profiling; Immunomodulation; Killer Cells, Natural; Lipopeptides; Lymphoid Progenitor Cells; Lymphoma, B-Cell; Mice; Mice, Transgenic; NF-kappa B; T-Lymphocytes; Toll-Like Receptor 2	2014
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:11 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lymphoma, B-Cell; Prednisone; Recurrence; Remission Induction; Risk; Rituximab; Salvage Therapy; Vidarabine; Vincristine; Virus Activation	2014
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents. British journal of haematology, 2015, Volume: 169, Issue:4 Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Benzamides; Boronic Acids; Bortezomib; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytarabine; Drug Resistance, Neoplasm; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Humans; Lymphoma, B-Cell; Male; Mice; Mice, SCID; Pyrazines; Pyridines; Rituximab; Xenograft Model Antitumor Assays	2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer, 2016, Feb-15, Volume: 122, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine	2016
A 43-year-old woman presenting with subacute, bilateral, sequential facial nerve palsies, then developing pseudotumour cerebri. BMJ case reports, 2015, Nov-24, Volume: 2015 Topics: Adult; Anticoagulants; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bell Palsy; Chemoradiotherapy; Chronic Disease; Cyclophosphamide; Cytarabine; Delayed Diagnosis; Dexamethasone; Doxorubicin; Female; Humans; Intracranial Hypertension; Lymphoma, B-Cell; Magnetic Resonance Imaging; Mastoid; Methotrexate; Optic Atrophy; Otitis Media, Suppurative; Papilledema; Pseudotumor Cerebri; Sinus Thrombosis, Intracranial; Treatment Outcome; Vincristine; Vision, Low	2015
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine	2016
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia. Annals of hematology, 2016, Volume: 95, Issue:11 Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Lymphoma, B-Cell; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Salvage Therapy; Urinary Bladder Neoplasms; Vincristine	2016
[Clinicopathological Features of Primary Central Nervous System Lymphoma and Their Influence on Prognosis of Desease]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:6 Topics: Aged; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Peripheral; Methotrexate; Prognosis; Rituximab	2016
Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases. Hematology (Amsterdam, Netherlands), 2008, Volume: 13, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cytarabine; Dexamethasone; Humans; Idarubicin; Immunohistochemistry; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged	2008
[A case of unclassified B-cell lymphosarcoma]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:7 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Diagnosis, Differential; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Remission Induction; Tomography, X-Ray Computed	2008
Efficacy and safety of modified rituximab-ESHAP therapy for relapsed/refractory B-cell lymphoma. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Rituximab	2010
Solitary intradural extramedullary lymphoma of the cervical spine. Journal of neurosurgery. Spine, 2010, Volume: 12, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cervical Vertebrae; Chemotherapy, Adjuvant; Cytarabine; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Rituximab; Spinal Neoplasms; Treatment Outcome	2010
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma. Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab	2010
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma. Cancer, 2010, Oct-01, Volume: 116, Issue:19 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Rituximab; Salvage Therapy; Treatment Outcome	2010
Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Cytarabine; Dexamethasone; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult	2010
Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. Bone marrow transplantation, 2011, Volume: 46, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrosourea Compounds; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Young Adult	2011
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%. British journal of haematology, 2011, Volume: 152, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult	2011
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with International journal of hematology, 2010, Volume: 92, Issue:5 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult	2010
Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatric blood & cancer, 2011, Volume: 56, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Developing Countries; Disease-Free Survival; Doxorubicin; Female; Folic Acid; Humans; Hydrocortisone; Iraq; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Survival Rate; Vincristine	2011
[Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas]. Orvosi hetilap, 2011, May-08, Volume: 152, Issue:19 Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine	2011
A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma. Journal of clinical and experimental hematopathology : JCEH, 2011, Volume: 51, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Proto-Oncogene Proteins c-bcl-2	2011
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma. International journal of hematology, 2011, Volume: 94, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome	2011
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012, Volume: 33, Issue:2 Topics: Cauda Equina; Cytarabine; Humans; Immunosuppressive Agents; Leukocyte Common Antigens; Lymphoma; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Radiotherapy	2012
Case of the season: Large B-cell lymphoma involving both breasts. Seminars in roentgenology, 2011, Volume: 46, Issue:4 Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary	2011
Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation. British journal of haematology, 2012, Volume: 157, Issue:3 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Melphalan; Radioimmunotherapy; Treatment Outcome; Yttrium Radioisotopes	2012
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines. Leukemia & lymphoma, 2012, Volume: 53, Issue:11 Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds	2012
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin. Medecine et maladies infectieuses, 2013, Volume: 43, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine	2013
Unusual implantation site of a port-a-cath system via the right femoral vein. Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Catheterization, Central Venous; Catheters, Indwelling; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Melphalan; Podophyllotoxin; Radiography; Thrombosis; Transplantation, Autologous	2002
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine	2002
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait. Pediatric hematology and oncology, 2003, Volume: 20, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine	2003
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9 Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prognosis; Sclerosis; Treatment Outcome	2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3. Cancer, 2003, Sep-01, Volume: 98, Issue:5 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prognosis; Treatment Outcome	2003
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:9 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Confidence Intervals; Cytarabine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Survival Analysis; Time Factors	2003
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]. Bulletin du cancer, 2004, Volume: 91, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa	2004
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients. European journal of haematology, 2004, Volume: 72, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine	2004
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. British journal of haematology, 2004, Volume: 125, Issue:5 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Salvage Therapy; Treatment Outcome	2004
Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside. American journal of hematology, 2004, Volume: 76, Issue:3 Topics: Adult; Breast Neoplasms; Cytarabine; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Uveitis, Anterior	2004
Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 1. Demonstration of CNS lymphoma by positron emission tomography scan affects management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-15, Volume: 22, Issue:14 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Prednisone; Tomography, Emission-Computed; Treatment Outcome; Vincristine	2004
[Treatment of primary mediastinal large B-cell lymphomas]. Orvosi hetilap, 2004, Dec-12, Volume: 145, Issue:50 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine	2004
[Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Przeglad lekarski, 2004, Volume: 61 Suppl 2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melphalan; Podophyllotoxin; Poland; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome	2004
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy]. No shinkei geka. Neurological surgery, 2005, Volume: 33, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pulse Therapy, Drug; Radiotherapy, Adjuvant; Remission Induction; Vincristine	2005
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897). Cancer, 2005, Aug-01, Volume: 104, Issue:3 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome	2005
A Case of Burkitt's Lymphoma Involving Both Breasts. Breast cancer (Tokyo, Japan), 2005, Volume: 12, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine	2005
Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins. Bone marrow transplantation, 2006, Volume: 37, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cryoglobulins; Cytarabine; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation, Autologous	2006
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Transplantation, Autologous; Treatment Outcome	2005
Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphoma. Oncology, 2005, Volume: 69, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome	2005
[High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vincristine	2006
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14). Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Retrospective Studies; Rituximab; Vincristine	2006
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. International journal of hematology, 2006, Volume: 83, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine	2006
Results of CHOP chemotherapy for diffuse large B-cell lymphoma. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2006, Volume: 39, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine	2006
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Incidence; Injections, Spinal; Kaplan-Meier Estimate; London; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Practice Guidelines as Topic; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome	2007
What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma? Leukemia & lymphoma, 2006, Volume: 47, Issue:12 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cytarabine; Dexamethasone; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prospective Studies; Recurrence; Rituximab; Salvage Therapy; Treatment Outcome	2006
Palifermin and palmar-plantar erythrodysesthesia. British journal of haematology, 2007, Volume: 136, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Hypersensitivity; Female; Fibroblast Growth Factor 7; Foot Dermatoses; Hand Dermatoses; Humans; Lymphoma, B-Cell; Melphalan; Middle Aged; Mitogens; Podophyllotoxin	2007
[The standard treatments for patients with hematological malignancies in Japan]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Rituximab; Survival Rate; Vincristine	2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italian Leukemia, 2007, Volume: 21, Issue:8 Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Rituximab; Transplantation, Autologous; Treatment Outcome	2007
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. American journal of hematology, 2007, Volume: 82, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chlamydophila psittaci; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Eye Neoplasms; Follow-Up Studies; Humans; Korea; Lymphoma, B-Cell; Polymerase Chain Reaction; Prednisone; Psittacosis; Retrospective Studies; Secondary Prevention; Sequence Analysis, DNA; Time Factors; Vincristine	2007
Gallium imaging in a patient with tumor lysis syndrome. Clinical nuclear medicine, 2007, Volume: 32, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Citrates; Cytarabine; Gallium; Humans; Lymphoma, B-Cell; Male; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Tumor Lysis Syndrome	2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone. Leukemia & lymphoma, 2007, Volume: 48, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome	2007
[Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Rituximab; Vincristine	2007
Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP. Transfusion, 2007, Volume: 47, Issue:8 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Transplantation, Homologous	2007
Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP). Pediatric blood & cancer, 2008, Volume: 50, Issue:6 Topics: Adolescent; Africa, Northern; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Infant; Lymphoma, B-Cell; Male; Methotrexate; Survival Rate	2008
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone marrow transplantation, 1995, Volume: 15, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukapheresis; Lymphocyte Count; Lymphocyte Subsets; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome; Vincristine	1995
Combination treatment of intraocular lymphoma. Retina (Philadelphia, Pa.), 1995, Volume: 15, Issue:2 Topics: Aged; Brain; Brain Neoplasms; Catheters, Indwelling; Chemotherapy, Adjuvant; Cytarabine; Eye Neoplasms; Female; Fundus Oculi; Humans; Injections, Spinal; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Orbit; Radiotherapy, Adjuvant; Retina; Vitrectomy; Vitreous Body	1995
Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics. Cancer research, 1994, Dec-15, Volume: 54, Issue:24 Topics: Animals; Bone Marrow; Bromodeoxyuridine; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Drug Synergism; Female; G1 Phase; G2 Phase; Lymphoma, B-Cell; Mice; Mice, Inbred C3H; Mitosis; S Phase; Time Factors	1994
Childhood B cell lymphomas arising in the mediastinum. Journal of clinical pathology, 1993, Volume: 46, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Immunohistochemistry; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Sclerosis; Superior Vena Cava Syndrome; Thoracotomy	1993
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone	1997
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome	1998
[Intensive treatment of T-cell-rich B lymphoma]. Sangre, 1998, Volume: 43, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lymphoma, B-Cell; Male; Melphalan; Podophyllotoxin; Prednisone; Remission Induction; T-Lymphocyte Subsets; Vincristine	1998
High-dose chemotherapy and autologous transplantation in lymphomatous polyposis in second remission: three case reports and literature review. Bone marrow transplantation, 1998, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Polyps; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Prednisone; Transplantation, Autologous; Vincristine	1998
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia, 1998, Volume: 12, Issue:9 Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Immunophenotyping; Infant; Infant, Newborn; Lymphoma, B-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone	1998
Clonal myelodysplastic cells present in apheresis product before transplantation. Leukemia, 1998, Volume: 12, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 7; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma, B-Cell; Lymphoma, Follicular; Melphalan; Middle Aged; Podophyllotoxin; Retrospective Studies	1998
Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor. Annals of hematology, 2000, Volume: 79, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Escherichia coli; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Prognosis; Respiratory Burst; Tetradecanoylphorbol Acetate	2000
Oncologist's nephropathy. Clinical oncology (Royal College of Radiologists (Great Britain)), 2000, Volume: 12, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cytarabine; Dexamethasone; Humans; Kidney Failure, Chronic; Lymphoma, B-Cell; Male; Middle Aged	2000
Diffuse bone increase uptake of gallium-67 related to cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rHuG-CSF) administration. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Gallium Radioisotopes; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Radionuclide Imaging; Recombinant Proteins; Tissue Distribution	2000
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:9 Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Immunohistochemistry; Lomustine; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prednimustine; Prednisone; Regression Analysis; Survival Analysis; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2000
Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation. Annals of hematology, 2000, Volume: 79, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Melphalan; Middle Aged; Remission Induction; Transplantation, Autologous	2000
Topoisomerase II inhibitor induced leukemia in a patient with AIDS. AIDS (London, England), 2001, Feb-16, Volume: 15, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors	2001
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. British journal of haematology, 2001, Volume: 112, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, B-Cell; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Treatment Outcome; Vincristine	2001
Acute cerebellar syndrome following intermediate-dose cytarabine. British journal of haematology, 2001, Volume: 113, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Brain; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Dysarthria; Gait Ataxia; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Nystagmus, Pathologic; Prednisone; Syndrome; Vincristine	2001
Chemotherapy-induced bullous acral erythema in a subject with B-cell lymphoma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2001, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Drug Eruptions; Erythema; Follow-Up Studies; Hand Dermatoses; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Risk Assessment; Skin Diseases, Vesiculobullous	2001
[Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group]. Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2 Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Laparotomy; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Risk Factors; Time Factors; Treatment Outcome; Vincristine	2000
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine	2002
TNF alpha therapy activates human B-lymphoma cells in vivo and may protect myelopoiesis. Leukemia research, 1992, Volume: 16, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow; Cytarabine; Female; Hematopoiesis; Humans; Lymphocyte Activation; Lymphoma, B-Cell; Male; Middle Aged; Mitoxantrone; Pilot Projects; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	1992
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma. Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:8 Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins	1992
Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma. Leukemia research, 1992, Volume: 16, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cefoperazone; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine	1992
'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). British journal of haematology, 1990, Volume: 76, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine	1990